Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMPARE STEMI ONE
2024-515883-30-00Phase 4Authorised
- Sponsor
- Research Cardiologen Rotterdam Zuid
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 4, randomised trial of prasugrel in myocardial infarction (MI) (4 arms), sponsored by Research Cardiologen Rotterdam Zuid. Primary endpoints: Net Adverse Clinical Events (NACE) and Post-procedural Minimal Stent Area (MSA). Planned start Jul 2024; status: authorised.
02
Drugs
prasugrel
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2024-515883-30-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515883-30-00.